NasdaqCM - Delayed Quote USD
Inhibikase Therapeutics, Inc. (IKT)
1.8600
-0.0500
(-2.62%)
At close: June 13 at 4:00:01 PM EDT
1.8600
0.00
(0.00%)
After hours: June 13 at 4:00:15 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BELLINI ROBERTO Director | Purchase | Oct 21, 2024 | -- |
| KUSH ARVIND Director | Purchase | Oct 21, 2024 | 145,000 |
| MUNSHI AMIT D Director | Purchase | Oct 21, 2024 | -- |
Related Tickers
DSGN Design Therapeutics, Inc.
3.8400
-1.79%
ANEB Anebulo Pharmaceuticals, Inc.
1.3900
+9.45%
ATHXQ Athersys, Inc.
0.0010
0.00%
SRZN Surrozen, Inc.
9.48
+0.82%
ABOS Acumen Pharmaceuticals, Inc.
1.0700
-6.14%
KZR Kezar Life Sciences, Inc.
4.5900
-4.18%
THRD Third Harmonic Bio, Inc.
5.43
+0.37%
AVIR Atea Pharmaceuticals, Inc.
3.1600
-1.56%
CRGX CARGO Therapeutics, Inc.
4.3900
-2.01%
MLYS Mineralys Therapeutics, Inc.
14.32
-4.02%